Skip to content

Moxibustion combined with Yiqi Wenyang Huoxue Recipe for angina pectoris after coronary revascularization: a large sample and multicenter randomized controlled trial

Moxibustion combined with Yiqi Wenyang Huoxue Recipe for angina pectoris after coronary revascularization: a large sample and multicenter randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070342
Enrollment
Unknown
Registered
2023-04-10
Start date
2023-04-10
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina pectoris after coronary revascularization

Interventions

treatment group:Heat-sensitive moxibustion+warming qi, yang and promoting blood circulation

Sponsors

Affiliated Hospital of Jiangxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. Age is 35 to 74 years old (inclusive), regardless of gender; 2. It meets the diagnostic criteria of western medicine for angina pectoris after coronary revascularization; 3. Patients who meet the diagnosis of traditional Chinese medicine and whose syndrome type belongs to the weakness of qi and yang; 4. Acupoint heat sensitivity appears in the area from the inside out to 6 inches at Xinshu and Juque points; 5. The patient is sane, can correctly express the sense of moxibustion, and cooperate with his behavior; 6. voluntary subjects, signed informed consent.

Exclusion criteria

Exclusion criteria: 1. those who are allergic to the known components of the research drug; 2. people who are intolerant of moxa smoke; 3. Recently, researchers with infection, trauma, etc. decided that they could not participate in the research; 4. Patients with severe cardiovascular diseases such as refractory heart failure, cardiogenic shock and severe valvular heart disease; 5. Patients with poor hypertension control (systolic blood pressure =160mmHg or diastolic blood pressure = 100 mmHg after treatment); 6. Patients with severe respiratory diseases such as severe pulmonary insufficiency; 7. Patients with severe liver and kidney diseases such as liver dysfunction (alanine aminotransferase or aspartate aminotransferase levels more than 2 times higher than normal, renal insufficiency (creatinine levels more than 2 times higher than normal); 8. Other serious diseases or conditions such as malignant tumor, severe anemia and severe renal artery stenosis; 9. Those who have contraindications to exercise treadmill test; 10. Participated in other clinical researchers in the last 2 months; 11. Women with positive pregnancy test, planned pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
Exercise treadmill test:TED;SAQ score;

Secondary

MeasureTime frame
1 minute heart rate recovery;Exercise treadmill test: metabolic equivalent;Exercise treadmill test: the maximum amplitude of ST segment depression;Exercise treadmill test: product of heart rate and blood pressure;Borg self-perceived fatigue score after exercise;Number of angina attacks per week;Use of nitroglycerin;Information scoring of four diagnostic methods in traditional Chinese medicine;Incidence rate of major adverse cardiovascular events;

Countries

China

Contacts

Public ContactWu Jianguang/Xiong Jun

Affiliated Hospital of Jiangxi University of Chinese Medicine

1074923070@qq.com+86 139 0700 3803

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026